Evidence map›Paper›PMID 28944597›Full record

ArticleObesity (Silver Spring, Md.)2017

Caloric Restriction-Induced Decreases in Dopamine Receptor Availability are Associated with Leptin Concentration.

Julia P Dunn, Naji N Abumrad, Robert M Kessler, Bruce W Patterson, Rui Li, Pamela Marks-Shulman, Robyn A Tamboli

Open access · bronzeAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Dopaminergic Control of the Feeding Circuit.Endocrinology and metabolism (Seoul, Korea) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Julia P DunnDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0001-9561-0183
Naji N AbumradDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Robert M KesslerDepartment of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Bruce W PattersonDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Rui LiDepartment of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Pamela Marks-ShulmanDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Robyn A TamboliVeterans Administration St. Louis Health Care System, St. Louis, Missouri, USA.ORCID 0000-0002-6398-935X
Vanderbilt University · USWashington University in St. Louis · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Role of the Omentum in the Treatment of Morbid ObesityR01DK070860 · NIDDK · VANDERBILT UNIVERSITY · PI ABUMRAD, NAJI N · 2005 to 2009
$4.2M
Vanderbilt Environmental Health Science Scholars ProgramK12ES015855 · NIEHS · VANDERBILT UNIVERSITY · PI BROWN, NANCY J. · 2007 to 2011
$3.5M
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue AxisR01DK091748 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ABUMRAD, NAJI N · 2011 to 2015
$3.0M
Insulin Resistance and Reward Signaling in ObesityIK2CX000943 · VA · ST. LOUIS VA MEDICAL CENTER · PI DUNN, JULIA PASSYN · 2015 to 2021
–
CSRD VA IK2 CX000943NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCRR NIH HHS UL1 RR024975NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK070860NIDDK NIH HHS R01 DK091748NIEHS NIH HHS K12 ES015855
6 · The paper itself

Abstract

objectiveIt has been previously reported that early after Roux-en-Y-gastric bypass, dopamine (DA) type 2 and 3 receptor (D2/3R) binding potential (BP

methodsFifteen females with obesity (BMI = 39 ± 6 kg/m

resultsWith the VLCD, weight decreased slightly (-3 kg). Insulin, glucose, and leptin decreased significantly, but there was no change in acyl ghrelin or measures from OMM. SN D2/3R BP

conclusionsIn obesity, reductions in regional D2/3R availability after VLCD are suggestive of increased endogenous DA competing with the radioligand. Changes in regional D2/3R availability were associated with decreases in leptin concentrations that occurred before clinically significant weight loss.

Indexed as

AdultBrainCaloric RestrictionFemaleHumansLeptinObesityReceptors, Dopamine D2LeptinReceptors, Dopamine D2

Identifiers

PMID28944597
PMCPMC5718041
OpenAlexW2759402069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.